Cough Medication: Evidence-Based Recommendations
Acute Cough (< 3–4 weeks)
For acute cough in adults and children, over-the-counter cough medications provide no proven benefit and should not be used. 1
- Acute cough is most commonly viral and self-limiting, requiring only supportive care 1
- Patients report subjective benefit from OTC preparations, but there is little evidence of specific pharmacological effect 1
- Do not give over-the-counter cough or cold medications to children—they provide no therapeutic benefit and may cause harm 2
- Antibiotics are not indicated for acute viral cough lasting < 4 weeks without signs of bacterial infection 3
When to Investigate Acute Cough Further
Pursue further workup if any of the following are present:
- Hemoptysis 1
- Prominent systemic illness 1
- Suspicion of inhaled foreign body 1
- Suspicion of lung cancer 1
Chronic Cough in Adults (> 8 weeks)
Initial Evaluation
All adults with chronic cough require chest radiograph and spirometry as mandatory first steps. 1
- Most chronic cough in adults results from upper airway cough syndrome (postnasal drip), asthma, gastroesophageal reflux disease, or nonasthmatic eosinophilic bronchitis 1, 4, 5
- These four conditions account for 90% of chronic cough cases 5
- The character, timing, and complications of cough do not reliably predict the underlying cause 5
Treatment Algorithm for Adults
1. Stop ACE inhibitors immediately if the patient is taking one—cough is unlikely to be corticosteroid-responsive if it persists after ACE inhibitor cessation. 1
2. For suspected asthma or eosinophilic bronchitis:
- Trial of inhaled corticosteroids (400 mcg/day budesonide equivalent) for 2 weeks 1
- If no response after 2 weeks of oral steroids, cough is unlikely due to eosinophilic airway inflammation 1
3. For suspected GERD:
- Proton pump inhibitor (omeprazole 40 mg daily or equivalent) plus dietary modification and lifestyle changes 1
- Add prokinetic therapy (metoclopramide 10 mg four times daily) if PPI alone is ineffective 1
- Treatment may take 8 weeks or longer to show benefit; some patients require months 1
4. For refractory chronic cough (failed empiric trials):
- Low-dose morphine is highly effective in a subset of patients with cough resistant to other treatments 6
- Gabapentin or pregabalin can be tried, though limited by adverse events 6, 4
- Dextromethorphan: effect size 0.37 for cough severity (95% CI 0.19–0.56, P = 0.0008) 7
- Opioid antitussives: effect size 0.55 for cough severity (95% CI 0.38–0.72, P < 0.0001) 7
- Speech therapy/cough suppression therapy when performed by competent practitioners 6
Benzonatate (FDA-Approved Antitussive)
For adults and children over 10 years: 100–200 mg three times daily as needed; maximum 600 mg daily in three divided doses 8
Critical safety warning: Benzonatate capsules must be swallowed whole—never broken, chewed, dissolved, cut, or crushed 8
Chronic Cough in Children (> 4 weeks)
Initial Classification
First, determine whether the cough is wet/productive or dry/non-productive—this distinction drives all subsequent management. 9
- Wet/productive cough suggests protracted bacterial bronchitis, bronchiectasis, or chronic suppurative lung disease 9
- Dry/non-productive cough may represent post-viral cough, asthma, or non-specific cough 9
Mandatory Initial Investigations
Obtain chest radiograph and spirometry (if child ≥ 3–6 years old) for all children with chronic cough. 1, 9
Red Flags ("Specific Cough Pointers")
Immediate further investigation required if any of the following are present:
- Coughing with feeding 1, 9
- Digital clubbing 1, 9
- Hemoptysis 9
- Failure to thrive 1
- Abnormal chest radiograph or spirometry 1, 9
Management Algorithm for Wet/Productive Cough in Children
1. First-line treatment (no specific pointers present):
- Prescribe 2 weeks of antibiotics targeting Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis based on local antibiotic sensitivities 1
- Amoxicillin-clavulanate is the most commonly used regimen 3
- If cough resolves within 2 weeks, diagnose protracted bacterial bronchitis (PBB) 1
2. If cough persists after 2 weeks:
3. If cough persists after 4 weeks total:
- Proceed to further investigations: flexible bronchoscopy with quantitative cultures, chest CT, assessment for aspiration, evaluation of immunologic competency 1, 9
- Refer to pediatric pulmonology 9
Management Algorithm for Dry/Non-Productive Cough in Children
1. Initial approach (no specific pointers present):
- Adopt a "watch, wait, and review" strategy—most cases are post-viral and resolve spontaneously 1, 9
- Review in 2–4 weeks to assess for resolution or development of specific pointers 9
2. Do NOT empirically treat for asthma unless:
- Cough worsens at night 2
- Episodes triggered by exercise or irritants 2
- Family history of asthma or atopy 2
- Other features consistent with asthma are present 9
3. If empirical trial of inhaled corticosteroids is warranted:
- Use 400 mcg/day budesonide equivalent for 2–3 weeks 1
- If no response, cease ICS and reconsider diagnosis 1, 9
4. If dry cough persists > 4 weeks:
- Perform systematic evaluation for chronic cough with chest radiograph and spirometry 9
- Consider flexible bronchoscopy if severe, persistent, or atypical presentation—68% of such infants have associated lower airway abnormalities 2
Environmental and Supportive Measures
Eliminate tobacco smoke exposure—this is a major contributor to chronic cough in both adults and children. 9, 10
- Ensure adequate hydration to thin secretions and facilitate clearance 9
- Avoid chest physiotherapy—it offers no benefit and may cause harm 2
- Antipyretics can be used for comfort in febrile children 2
Critical Pitfalls to Avoid
- Never use combination cough preparations—they should not be prescribed 10
- Never give OTC cough medications to children—they lack proven efficacy and carry risk of serious adverse effects 2, 9
- Never give antihistamines or decongestants for cough—they are ineffective and carry potential adverse effects 2
- Never use honey for acute cough—it is only helpful for post-viral cough, not inflammatory airway conditions 2
- Never empirically treat for GERD, asthma, or upper airway cough syndrome without specific clinical features supporting these diagnoses 9
- Never discharge a child within 2 hours of nebulized epinephrine (if given for croup-like presentation) due to risk of rebound symptoms 2